Starling Oncology, Inc.
STLNW- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $163.5K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Starling Oncology, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +1 vs. Q3 2022
- Shares held
- 4.05M
- +698.5K (+20.8%) vs. Q3 2022
- Total value
- $346.4K
- −$1.38M (−79.9%) vs. Q3 2022
- New holders
- 3
- 1 more added
- Sold out
- 2
- 2 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STLNW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $163.5K |
| Q1 2026 | 11 | $172.4K |
| Q4 2025 | 11 | $465.1K |
| Q3 2025 | 12 | $469.0K |
| Q2 2025 | 11 | $195.4K |
| Q1 2025 | 11 | $94.9K |
| Q4 2024 | 14 | $19.0K |
| Q3 2024 | 15 | $52.0K |
| Q2 2024 | 18 | $108.0K |
| Q1 2024 | 15 | $827.5K |
| Q4 2023 | 16 | $806.9K |
| Q3 2023 | 15 | $406.9K |
| Q2 2023 | 15 | $132.4K |
| Q1 2023 | 17 | $232.3K |
| Q4 2022 | 14 | $346.4K |
| Q3 2022 | 14 | $1.78M |
| Q2 2022 | 13 | $1.61M |
| Q1 2022 | 14 | $3.90M |
| Q4 2021 | 22 | $2.56M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Starling Oncology, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 1,250,000 | $137.6K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $62.0K | 0.00% | – | – |
| Walleye Capital LLC | 355,410 | $39.1K | 0.00% | +355,410 | New |
| Davidson Kempner Capital Management LP | 318,710 | $35.0K | 0.00% | 00.0% | Unchanged |
| Cowen and Company, LLC | 120,100 | $13.2K | 0.00% | +120,100 | New |
| Difesa Capital Management, LP | 115,975 | $12.8K | 0.01% | 00.0% | Unchanged |
| Jefferies Financial Group Inc. | 95,000 | $10.5K | 0.00% | +95,000 | New |
| Man Group plc | 94,740 | $10.4K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 93,632 | $10.3K | 0.00% | −10,058−9.7% | Reduced |
| Healthcare of Ontario Pension Plan Trust Fund | 87,500 | $9.63K | 0.00% | 00.0% | Unchanged |
| Alpine Global Management, LLC | 25,024 | $3.00K | 0.00% | 00.0% | Unchanged |
| Tenor Capital Management Co., L.P. | 25,000 | $2.75K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 610 | $67 | 0.00% | −4,889−88.9% | Reduced |
| LMR Partners LLP | 1,469,464 | – | – | +262,954+21.8% | Added |
| Union Square Park Capital Management, LLC | 0 | $0 | 0.00% | −120,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | – | Sold out |
| Jefferies Group LLC | – | – | – | – | Not filed |